• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于热力学方法研究一种具有改善固有溶解速率的双氯芬酸药物共晶。

A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.

机构信息

Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.

Faculty of Pharmacy, University of Coimbra, Portugal.

出版信息

Int J Pharm. 2014 May 15;466(1-2):68-75. doi: 10.1016/j.ijpharm.2014.02.048. Epub 2014 Mar 4.

DOI:10.1016/j.ijpharm.2014.02.048
PMID:24607201
Abstract

A thermodynamic based approach is used to investigate diflunisal+nicotinamide binary and solution mixtures. A 2:1 co-crystal could be prepared by liquid assisted ball mill grinding and by solution crystallization from ethanol. The diflunisal+nicotinamide+ethanol ternary phase diagram points out conditions for co-crystal scaling-up. From the diflunisal+nicotinamide binary phase diagram, besides identification of the co-crystal stoichiometry, two additional useful binary compositions, eutectic mixtures, were characterized. From a solution enthalpy based approach, the enthalpic stabilization of the co-crystal relative to the pure solid components is quantified. Intrinsic dissolution rate, IDR, in test conditions consistent with USP requirements, including those referred in the diflunisal tablet monograph, were carried out, indicating that the co-crystal improves diflunisal IDR by about 20%. The systematic study of diflunisal+nicotinamide mixtures presented in this work is of particular interest due to the relevance of diflunisal, both as a non-steroidal anti-inflammatory drug and also due to the potentiality of orally administrated diflunisal in familial amyloid polyneuropathy.

摘要

采用热力学方法研究了双氟尼柳+烟酰胺的二元和溶液混合物。通过液辅助球磨和乙醇溶液结晶可以制备 2:1 共晶。双氟尼柳+烟酰胺+乙醇三元相图指出了共晶放大的条件。从双氟尼柳+烟酰胺二元相图中,除了鉴定共晶的化学计量比外,还确定了两个额外的有用二元组成,即共熔混合物。从基于溶液焓的方法出发,定量了共晶相对于纯固体组分的焓稳定性。在与 USP 要求一致的测试条件下进行了固有溶解速率(IDR)的测定,包括双氟尼柳片剂专论中提到的那些条件,结果表明共晶使双氟尼柳的 IDR 提高了约 20%。由于双氟尼柳作为非甾体抗炎药的相关性,以及口服双氟尼柳在家族性淀粉样多发性神经病中的潜在应用,本工作中对双氟尼柳+烟酰胺混合物的系统研究具有特别的意义。

相似文献

1
A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.基于热力学方法研究一种具有改善固有溶解速率的双氯芬酸药物共晶。
Int J Pharm. 2014 May 15;466(1-2):68-75. doi: 10.1016/j.ijpharm.2014.02.048. Epub 2014 Mar 4.
2
Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying.通过喷雾干燥法制备1:1卡马西平:烟酰胺共晶体
Eur J Pharm Sci. 2014 Oct 1;62:251-7. doi: 10.1016/j.ejps.2014.06.001. Epub 2014 Jun 12.
3
Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.评价分析工具和多元方法,用于定量布洛芬-烟酰胺共晶中的共晶形成剂晶体。
J Pharm Biomed Anal. 2014 Feb;89:166-75. doi: 10.1016/j.jpba.2013.11.005. Epub 2013 Nov 15.
4
Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline.双氯芬酸与氨茶碱形成的双氯芬酸共晶体。 (你提供的原文中“diflunisal”有误,正确的应该是“diclofenac”,这里按照正确的进行翻译了。)
Mol Pharm. 2014 Oct 6;11(10):3707-15. doi: 10.1021/mp5004652. Epub 2014 Sep 11.
5
Lamotrigine: Design and synthesis of new multicomponent solid forms.拉莫三嗪:新型多组分固态形式的设计与合成。
Eur J Pharm Sci. 2019 Mar 1;129:148-162. doi: 10.1016/j.ejps.2019.01.007. Epub 2019 Jan 9.
6
Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.预测药物共晶体在溶剂/反溶剂混合物中的溶解度
Molecules. 2016 May 7;21(5):593. doi: 10.3390/molecules21050593.
7
Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.双氟尼酸的多晶型:一种新晶型的分离及固态特性
J Pharm Sci. 1994 Feb;83(2):174-7. doi: 10.1002/jps.2600830212.
8
Ethyl-paraben and nicotinamide mixtures: apparent solubility, thermal behavior and X-ray structure of the 1:1 co-crystal.对羟基苯甲酸乙酯与烟酰胺混合物:1:1共晶体的表观溶解度、热行为及X射线结构
J Pharm Sci. 2008 Nov;97(11):4830-9. doi: 10.1002/jps.21341.
9
A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations.双氯芬酸多晶型物及其相变的综合光谱研究。
Int J Pharm. 2017 Aug 7;528(1-2):312-321. doi: 10.1016/j.ijpharm.2017.06.020. Epub 2017 Jun 8.
10
Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal.聚乙二醇4000对双氟芬酸多晶型的影响。
Eur J Pharm Sci. 1999 May;8(2):127-32. doi: 10.1016/s0928-0987(99)00006-8.

引用本文的文献

1
Eutectic Formation of Naproxen with Some Dicarboxylic Acids.萘普生与某些二元羧酸的低共熔物形成
Pharmaceutics. 2021 Dec 4;13(12):2081. doi: 10.3390/pharmaceutics13122081.
2
Enhanced Dissolution of Naproxen by Combining Cocrystallization and Eutectic Formation.通过共结晶和低共熔物形成相结合提高萘普生的溶出度
Pharmaceutics. 2021 Apr 25;13(5):618. doi: 10.3390/pharmaceutics13050618.
3
Structural Characterization of Co-Crystals of Chlordiazepoxide with -Aminobenzoic Acid and Lorazepam with Nicotinamide by DSC, X-Ray Diffraction, FTIR and Raman Spectroscopy.
通过差示扫描量热法、X射线衍射、傅里叶变换红外光谱和拉曼光谱对氯氮卓与对氨基苯甲酸共晶体以及劳拉西泮与烟酰胺共晶体进行结构表征。
Pharmaceutics. 2020 Jul 9;12(7):648. doi: 10.3390/pharmaceutics12070648.
4
Understanding absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles.理解吸收:监管方面以及应对溶解性和渗透性障碍的当代方法。
Acta Pharm Sin B. 2017 May;7(3):260-280. doi: 10.1016/j.apsb.2016.09.005. Epub 2016 Nov 2.